These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 9366431)

  • 1. Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody.
    Mauri C; Chu CQ; Woodrow D; Mori L; Londei M
    J Immunol; 1997 Nov; 159(10):5032-41. PubMed ID: 9366431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
    Chu CQ; Londei M
    J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies.
    Chiocchia G; Boissier MC; Fournier C
    Eur J Immunol; 1991 Dec; 21(12):2899-905. PubMed ID: 1836185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of monoclonal antibodies to alpha beta TCR but not to CD4 on collagen-induced arthritis in the rat.
    Goldschmidt TJ; Holmdahl R
    Cell Immunol; 1994 Mar; 154(1):240-8. PubMed ID: 7907007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell receptor V beta 8 has no significant suppressive effect on collagen-induced arthritis.
    Matsuno H; Kadowaki KM; Suzuki H; Ochiai H; Tsuji H
    Int J Tissue React; 1993; 15(1):1-9. PubMed ID: 8282479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen.
    Garcia G; Komagata Y; Slavin AJ; Maron R; Weiner HL
    J Autoimmun; 1999 Nov; 13(3):315-24. PubMed ID: 10550219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
    Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
    Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
    Marinova-Mutafchieva L; Williams RO; Mauri C; Mason LJ; Walmsley MJ; Taylor PC; Feldmann M; Maini RN
    Arthritis Rheum; 2000 Mar; 43(3):638-44. PubMed ID: 10728758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen-induced arthritis and TCRs in SWR and B10.Q mice expressing an Ek alpha transgene.
    Griffiths MM; Nabozny GH; Hanson J; Harper DS; McCall S; Moder KG; Cannon GW; Luthra HS; David CS
    J Immunol; 1994 Sep; 153(6):2758-68. PubMed ID: 8077680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process.
    Mauri C; Mars LT; Londei M
    Nat Med; 2000 Jun; 6(6):673-9. PubMed ID: 10835684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of dose of type II collagen in suppression of collagen-induced arthritis by nasal tolerance.
    Derry CJ; Harper N; Davies DH; Murphy JJ; Staines NA
    Arthritis Rheum; 2001 Aug; 44(8):1917-27. PubMed ID: 11508445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-1BB-mediated immunotherapy of rheumatoid arthritis.
    Seo SK; Choi JH; Kim YH; Kang WJ; Park HY; Suh JH; Choi BK; Vinay DS; Kwon BS
    Nat Med; 2004 Oct; 10(10):1088-94. PubMed ID: 15448685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
    Iwanami K; Matsumoto I; Tanaka-Watanabe Y; Inoue A; Mihara M; Ohsugi Y; Mamura M; Goto D; Ito S; Tsutsumi A; Kishimoto T; Sumida T
    Arthritis Rheum; 2008 Mar; 58(3):754-63. PubMed ID: 18311788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
    Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
    Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological activities on T lymphocytes of a baculovirus-expressed chimeric recombinant IgG1 antibody with specificity for the CDR3-like loop on the D1 domain of the CD4 molecule.
    Troadec S; Bès C; Chentouf M; Nguyen B; Briant L; Jacquet C; Chebli K; Pugnière M; Roquet F; Cerutti M; Chardès T
    Clin Immunol; 2006 Apr; 119(1):38-50. PubMed ID: 16426893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
    Williams RO
    Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo elimination of T cells expressing specific T-cell receptor V beta chains in mice susceptible to collagen-induced arthritis.
    Goldschmidt TJ; Jansson L; Holmdahl R
    Immunology; 1990 Apr; 69(4):508-14. PubMed ID: 2139866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of immune responses in collagen-induced arthritis by a rationally designed CD80-binding peptide agent.
    Srinivasan M; Eri R; Zunt SL; Summerlin DJ; Brand DD; Blum JS
    Arthritis Rheum; 2007 Feb; 56(2):498-508. PubMed ID: 17265485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.